← Back to Search

Experimental: Safety Behavior Fading for Social Anxiety

N/A

Recruiting

Research Sponsored by Florida State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up time frame: day 0, day 14, day 28, day 56

Awards & highlights

Study Summary

This trial will test how well text messages can help people form healthy habits.

Who is the study for?

This trial is for individuals with social anxiety, as indicated by a score greater than 29 on the Social Phobia Inventory. Participants must have been on stable psychotropic medications for at least four weeks and should not be currently receiving psychotherapy specifically for social anxiety.Check my eligibility

What is being tested?

The study is testing a text message-based intervention designed to reduce safety behaviors that people with social anxiety might rely on. It's being compared to an active control group to measure its effectiveness in managing symptoms of social anxiety.See study design

What are the potential side effects?

Since this trial involves behavioral interventions through text messaging rather than medication or medical procedures, traditional physical side effects are not expected. However, participants may experience increased anxiety or discomfort when reducing their safety behaviors.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ time frame: day 0, day 14, day 28, day 56

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~time frame: day 0, day 14, day 28, day 56

This trial's timeline: 3 weeks for screening, Varies for treatment, and time frame: day 0, day 14, day 28, day 56 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Social Phobia Inventory (SPIN)

Secondary outcome measures

Change in Center For Epidemiological Studies Depression Scale, Ten Item Version (CESD-10)

Change in Self-Beliefs Related to Social Anxiety Scale (SBSA)

Change in Subtle Avoidance Frequency Examination (SAFE) scale

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Experimental: Safety Behavior FadingExperimental Treatment1 Intervention

This treatment lasts a total of 28 days. Participants will be asked to identify common safety behaviors related to social anxiety. For the next 14 days, participants will receive instructions to fade out these behaviors. After 14 days, participants will be asked to re-select their target safety behaviors and continue to reduce them over the next two weeks.

Group II: Unhealthy Behavior FadingActive Control1 Intervention

This treatment lasts a total of 28 days. Participants will be asked to identify common unhealthy behaviors related to social anxiety. For the next 14 days, participants will receive instructions to fade out these behaviors. After 14 days, participants will be asked to re-select their target unhealthy behaviors and continue to reduce them over the next two weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Safety Behavior Fading for Social Anxiety

2021

N/A

~160

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Florida State UniversityLead Sponsor

200 Previous Clinical Trials

31,634 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any positions still available to participants in this experiment?

"According to information on clinicaltrials.gov, this medical trial is not currently accepting patients; the initial posting was on January 1st 2024 and the most recent update happened in December 5th 2023. However, there are 449 other trials that are actively seeking out participants right now."

Answered by AI